Background
==========

High prevalence of sulfonamide resistance has been observed in Gram-negative bacteria from animals and humans all over the world \[[@B1]-[@B5]\]. In Denmark, sulfonamides are one of the most frequently used antimicrobials to treat diseases in pigs and sulfonamide resistance prevalence in *Escherichia coli*is relatively high along the food chain from pigs to pork and humans \[[@B3],[@B5],[@B6]\]. In contrast to the many different resistance genes described for other classes of antimicrobials, so far there are only three genes (*sul1*, *sul2*and *sul3*) which have been identified encoding sulfonamide resistance \[[@B4],[@B7]\]. *Sul1*has almost exclusively been found on large conjugative plasmids and on class 1 integrons \[[@B3],[@B6],[@B8],[@B9]\]. *Sul2*was previously considered to be located on small non-conjugative plasmids, but recently the gene has also been found on a wide range of large conjugative plasmids \[[@B1],[@B8]\] and have been linked to the prevalence of streptomycin resistance \[[@B3]\]. *Sul3*was originally described from pigs in Switzerland in 2003 and has since been reported in animals as well as humans in many countries. A recent publication has linked *sul3*to non-classic class 1 integrons \[[@B10]\]. However, knowledge about the structure and circulation of plasmids carrying *sul3*has yet not been well described yet \[[@B7]\].

Genetic localization of *sul*genes on efficient mobile genetic structures probably contribute to the wide spread of sulfonamides resistance. Plasmids unavoidably play an important role in carrying and mobilizing *sul*genes \[[@B8]\]. The identification of plasmids associated with specific *sul*genes therefore helps understanding the mobilization capability of *sul*-genes among different bacterial species and enables determination of how sulfonamide resistance disseminates in different environments. Currently little is known about plasmid backbones associated with various *sul*genes especially in different reservoirs, e.g. animals and human \[[@B1],[@B9]\]. The aims of this study were therefore to investigate the prevalence of the sulfonamide resistance genes (*sul1, sul2*and *sul3*) in *E. coli*through the food chain from pigs to slaughter (pig carcasses) and humans and to assess the genetic diversity of plasmid, based on size and replicon, involved in the mobility of various *sul*genes from the three sources.

Methods
=======

Bacterial strain collection
---------------------------

A total of 501 *E. coli*isolates collected from three sources were included in this study: 150 isolates were obtained in 2007 from fecal samples of Danish pigs as part of the Danish Integrated Antimicrobial Resistance Monitoring and Research Program (DANMAP) \[[@B5]\]; 275 isolates were obtained from pig carcasses in a Danish pig slaughterhouse in November 2007 \[[@B11]\]; and 76 isolates were obtained from stool samples of Danish healthy humans between May and June 2008, of which only two had been travelling abroad within three months before sampling \[[@B12]\].

Sampling and strain isolation for *E. coli*from pig feces has been described previously \[[@B5],[@B11],[@B12]\]. Only one isolate was collected from each pig fecal and human stool sample. Multiple isolates were collected from each pig carcass sample, but only representative isolates with distinct pulsed-field gel electrophoresis (PFGE) patterns were included in the characterization of plasmids.

Antimicrobial susceptibility testing
------------------------------------

Antimicrobial resistance profiles for all isolates were determined by an automated microdilution method (Trek Diagnostic Systems, East Grinstead, UK) for 17 antimicrobial agents included in DANMAP \[[@B5]\]. The results were interpreted in accordance with EUCAST guidelines \[[@B13]\], where the Minimum Inhibitory Concentration (MIC) breakpoint for sulfamethoxazole resistance is \> 256 mg/L.

Detection of sul genes and integrons
------------------------------------

Multiplex PCR was performed on boiled cell lysates of the sulfonamide-resistant isolates. Primers developed by Kerrn *et al.*\[[@B14]\] were used for detection of *sul1*and *sul2*and a new primer-set for *sul3*was designed for this study (*sul3*-F: 5\'-CAGATAAGGCAATTGAGCATGCTCTGC-3\', *sul3*-R: 5\'-AGAATGATTTCCGTGACACTGCAATCATT-3\'). PCR was performed in a 20 μL mixture, including 2 μL template DNA, 3 μL 10× reaction buffer (Ampliqon, Herlev, Denmark); 1 μL MgCl~2~(25 mM; Ampliqon); 0.25 μL dNTPs; 0.25 μL Taq Polymerase (50 mM, Ampliqon); 2.5 μL forward and reverse primer mixture (volume for *sul1*:*sul2*:*sul3*= 1:1:2). Amplification was carried out by heating for 5 min at 94°C, followed by 30 cycles at 94°C for 1 min, 68°C for 1 min and 72°C for 2 min, followed by 72°C for 10 min. The sizes of the amplicon were 433 bp for *sul1*, 293 bp for *sul2*and 569 bp for *sul3*. Presences of class 1 and class 2 integrons were detected by primers for integrase 1 and integrase 2 described previously \[[@B14],[@B15]\]. Positive and negative controls were included in all PCR arrays.

Plasmid-mediated sulfonamide resistance transferability
-------------------------------------------------------

A proportion of sulfonamide-resistant *E. coli*isolates (18 from humans, 18 from pig feces and 21 from pig carcasses) representing different *sul*genes were selected for further plasmid characterization. Conjugation experiments were performed at 37°C by filter mating assay using *E. coli*K12-J53 (nalidixic acid-resistant) as recipient and transconjugants were selected on Mueller-Hinton agar plates supplemented 256 mg/L sulfamethoxazole and 40 mg/L nalidixic acid.

When donor strains were resistant to nalidixic acid or resistance plasmid transfer failed in the mating experiments or when plasmid co-transfer occurred, electroporation was done to obtain recipients with single plasmid carrying *sul*genes. Plasmid DNA was purified by the QIAGEN Plasmid Mini kit (Qiagen, Hilden, Germany) as described by the manufacturer. Purified plasmids were used to transform ElectroMAX™DH10B™competent cells (Invitrogen, Paisley, United Kingdom) using a Bio-Rad MicroPulser (Bio-Rad Laboratories, CA, USA) under standard conditions (1.8 kv, 180 Ω and 25 μF). Transformants were selected on Mueller-Hinton agar plates supplemented with 256 mg/L sulfamethoxazole and confirmed to harbor corresponding *sul*genes by multiplex PCR assay as described earlier.

S1 nuclease digestion of plasmids and PFGE
------------------------------------------

S1 nuclease digestion followed by PFGE was performed to visualize and determine the molecular size of plasmids \[[@B14]\]. Agarose plugs were prepared according to the *PulseNet*protocol \[[@B16]\] except the concentration of the cells was adjusted to 0.83-0.85 on a Dade Micoscan turbidity meter (Dade Behring, CA, USA). Slices of plugs were digested with 5 U of S1 nuclease (Promega, Madison, WI, USA) for 45 min at 37°C. The plasmids were separated in a 1% SeaKem Gold agarose (Cambrex, East Rutherford, NJ, USA) gel using the CHEF DR III System (Bio-Rad, Hercules, CA) in 0.5× Tris-borate EDTA at 14°C and an angle of 120 at 6 V/cm gradient with pulse ramping from 6.8 to 38.4 s over 18 h.

Plasmid replicon type determination
-----------------------------------

Plasmids from parental and transformant/transconjugant strains were assigned to 18 incompatibility (Inc) groups by PCR-based replicon typing (PBRT) of total DNA using previously described primers and conditions \[[@B17]\]. IncQ was screened as described previously \[[@B18]\]. The presence of IncX1 was investigated using the primers (IncX1-F: 5\'-GCAGATTGATTCACGTGAAG-3\', IncX1-R 5\'-CCTCTGAAACCGTATGGTATTC-3\'). All positive results generated by multiplex PCR were confirmed using single primer pair.

Results and discussion
======================

Prevalence of sulfonamide resistant E. coli and sul genes
---------------------------------------------------------

A total of 109 sulfonamide resistant *E. coli*isolates were detected and prevalences of sulfonamide resistance were 17% for pig feces (26/150), 18% from pig carcasses (49/275) and 45% from humans stool (34/76) (Table [1](#T1){ref-type="table"}). The prevalence of *sul1*gene varied from 23% to 29% in *E. coli*from the three sources. The *sul2*gene was the most prevalent sulfonamide resistance gene found in all of the three sources (\> 40%). The *sul3*gene was present alone in 9% of pig feces and 10% of pig carcasses, while in human isolates it was detected simultaneously with *sul2*in two *E. coli*isolates. The presence of two *sul*genes was detected in *E. coli*from all sources (18% from pig feces, 20% from pig carcasses and 31% from humans).

###### 

Prevalence of *sul1*, *sul2*and *sul3*genes in sulfonamide-resistant *E. coli*isolated from pig feces, pig carcasses and human stools

  Origin        No. of isolates tested   No. of isolates with *sul*genes (percentage)                        
  ------------- ------------------------ ---------------------------------------------- ---------- --------- -------------
  Human stool   26                       6 (23%)                                        12 (46%)   0         8 (31%)^a^
  Pig carcass   49                       13 (27%)                                       21 (43%)   5 (10%)   10 (20%)^b^
  Pig feces     34                       10 (29%)                                       15 (44%)   3 (9%)    6 (18%)^c^

^a^Six strains were positive for both *sul1*and *sul2*; two strains contained both *sul2*and *sul3*.

^b^Seven strains contained both *sul1*and *sul2*; one strain contained *sul1*and *sul3*; and two strains harbored *sul2*and *sul3*.

^c^Six strains contained both *sul1*and *sul2*.

A higher prevalence of *sul2*than *sul1*and *sul3*in *E. coli*from animals and humans has been observed in previous studies in Denmark as well as in other countries \[[@B3],[@B6],[@B14],[@B19],[@B20]\]. In the UK, sulfonamide resistance in human *E. coli*persists undiminished with *sul2*maintaining dominant despite that the human usage of sulfonamides had been terminated decades ago\[[@B1],[@B2]\]. We found that *sul3*occurred with the lowest prevalence of the three *sul*genes among all *E. coli*from the three sources, which corresponds to previous observations \[[@B3],[@B6],[@B9],[@B21],[@B22]\]. The higher prevalence of combined *sul*genes in human *E. coli*isolates compared with food animal isolates was also observed in earlier studies \[[@B3],[@B6]\]. This is likely due to the acquisition of additional genes from different sources (animals, food and environment), as well as the selective pressure by the human\'s consumption of antimicrobial agents.

Sulfonamides are widely used in Danish veterinary practice. Combined formulations of sulfonamide/trimethoprim have been frequently used in Danish pig production \[[@B5]\]. This may explain why sulfonamide resistance occurs with high prevalence in *E. coli*isolates from Danish pigs. From the previous epidemiological study of the human isolates included in this investigation no strong correlation between prevalence of sulfonamide resistance in isolates of human origin and human usage of sulfonamides could be found.

Transferability of sul genes
----------------------------

A total of 57 sulfonamide-resistant *E. coli*isolates (18 from pig feces, 21 from pig carcasses and 18 from humans) were included for conjugation assay and plasmid analysis. Conjugative plasmids were successfully transferred from 42 isolates (82%), including 22 isolates where the *sul*plasmids were co-transferred with another plasmid (data not shown). Electro-transformation was conducted to ensure transconjugants containing only one plasmids encoding for *sul*-resistance. This was performed for the 22 isolates containing multiple conjugative plasmids, including 9 *E. coli*isolates with non-conjugative plasmids and 6 isolates showing resistance to nalidixic acid. The results showed, that 53/57 transconjugants/transformants obtained a single *sul*gene, while the remaining four isolates (all from humans) contained single plasmids of different sizes carrying both *sul1*and *sul2*genes (Table [2](#T2){ref-type="table"}).

###### 

Characterization of *sul*genes and plasmids in 57 *E. coli* isolates.

  ---------------------------------------------------------------------------------------------------------------------------------------
  *sul*gene located\   Strain ID    Sample source   Inc group       Plasmid size\   Co-transferred resistance   Conjugative   Integrase
  on plasmids                                                       (kb)                                                      
  -------------------- ------------ --------------- --------------- --------------- --------------------------- ------------- -----------
  *sul1*               70-7-3       pig feces       I1              60              TET TMP                     Yes           *IntI1*

  *sul1*               70-10-1      pig feces       I1              78              STR SPE TET                 Yes           *IntI1*

  *sul1*               70-13-2      pig feces       I1              140             STR SPE                     Yes           *IntI1*

  *sul1*               70-58-1      pig feces       I1              78              SPE TET                     Yes           *IntI1*

  *sul1*               v3-s1-8-4    pig carcass     I1              78              TET TMP                     Yes           *IntI1*

  *sul1*               v2-f2-2      pig carcass     N               33              TET TMP                     Yes           *IntI1*

  *sul1*               v2-s3-3-10   pig carcass     N               33              TET TMP                     Yes           *IntI1*

  *sul1*               v2-s3-2-3    pig carcass     FIB             105             SPE STR                     Yes           *IntI1*

  *sul1*               3847         human stool     FIB             80              AMP SPE STR                 Yes           *IntI1*

  *sul1*               v4-s1-20-3   pig carcass     HI1             160             SPE STR TET                 Yes           *IntI1*

  *sul1*               70-7-2       pig feces       FII             45              AMP                         Yes           

  *sul1*               3796         human stool     FIA, FIB        95              AMP AUG GEN TMP             No            

  *sul1*               3880         human stool     FIA, FIB        78              TMP                         No            

  *sul1*               3849         human stool     FIB, FII        80              STR                         No            

  *sul1*               3846         human stool     B/O             55              AMP AUG                     Yes           

  *sul1*               70-138-3     pig feces       Unknown         85              STR TMP                     No            *IntI1*

  *sul1*               3806         human stool     Unknown         40              AMP TET TMP                 Yes           *IntI1*

                                                                                                                              

  *sul2*               70-13-7      pig feces       FII             55              AMP                         Yes           

  *sul2*               70-165-18    pig feces       FII             45              AMP                         Yes           

  *sul2*               70-13-9      pig feces       FII             55              AMP STR                     Yes           

  *sul2*               70-56-3      pig feces       FII             55              AMP STR TMP                 Yes           

  *sul2*               70-58-2      pig feces       FII             40              AMP STR TMP                 Yes           

  *sul2*               v2-f3-2      pig carcass     FII             50              AMP                         Yes           

  *sul2*               v2-s1-3-5    pig carcass     FII             45              AMP STR                     Yes           

  *sul2*               v3-s1-2-8    pig carcass     FII             55              AMP STR                     Yes           

  *sul2*               v4-s3-17-3   pig carcass     FII             40              AMP STR                     Yes           

  *sul2*               v2-f3-6      pig carcass     FII             55              AMP STR TET TMP             Yes           

  *sul2*               v2-s1-1-10   pig carcass     FII             55              AMP GEN STR TMP             Yes           

  *sul2*               3783         human stool     FII             50              AMP TMP                     \--^a^        

  *sul2*               3816         human stool     FII             33              AMP STR TET TMP             No            

  *sul2*               3837         human stool     FII             33              AMP STR TET TMP             No            

  *sul2*               3859         human stool     FII             55              STR                         \--           

  *sul2*               70-141-6     pig feces       FIB             120             TET                         Yes           

  *sul2*               70-166-11    pig feces       B/O             80              TMP                         Yes           *IntI2*

  *sul2*               70-10-6      pig feces       B/O             70              AMP STR TET                 Yes           *IntI1*

  *sul2*               70-11-5      pig feces       B/O             78              AMP STR SPE TMP             Yes           

  *sul2*               3841         human stool     B/O             55              AMP STR                     Yes           

  *sul2*               v2-s1-1-8    pig carcass     I1              50              AMP SPE STR TMP             \--           

  *sul2*               3834         human stool     FIA, FIB        60              AMP GEN STR TET TMP         \--           *IntI1*

  *sul2*               v2-s3-1-8    pig carcass     Unknown         45              AMP STR                     Yes           

  *sul2*               3815         human stool     Unknown         80              AMP SPE STR                 Yes           *IntI1*

  *sul2*               3810         human stool     Unknown         95              STR                         \--           *IntI1*

                                                                                                                              

  *sul1+2*             3853         human stool     FIB             130             AMP CHL STR TET TMP         No            *IntI1*

  *sul1+2*             3823         human stool     FIB             139             AMP STR TMP                 \--           

  *sul1+2*             3872         human stool     FIB, FII        100             STR TET TMP                 No            

  *sul1+2*             3881         human stool     FIA, FIB, FII   110             GEN STR TET TMP             No            

                                                                                                                              

  *sul3*               70-13-1      pig feces       I1              80              CHL                         Yes           *IntI1*

  *sul3*               70-11-1      pig feces       I1              78              \-\-\--                     Yes           *IntI1*

  *sul3*               v2-s3-3-6    pig carcass     I1              78              \-\-\--                     Yes           *IntI1*

  *sul3*               v2-s3-2-4    pig carcass     I1              78              CHL SPE STR TMP             Yes           *IntI1*

  *sul3*               v4-s3-3-4    pig carcass     I1              55              CHL                         Yes           *IntI1*

  *sul3*               V3-s3-2-4    pig carcass     X1              115             AMP NEO SPE TMP             Yes           *IntI1*

  *sul3*               v4-f1-2      pig carcass     FII             78              CHL                         Yes           *IntI1*

  *sul3*               v4-s1-20-4   pig carcass     FIB, FIC        65              SPE                         Yes           *IntI1*

  *sul3*               70-8-1       pig feces       FIB, FIC        78              SPE                         Yes           *IntI1*

  *sul3*               v4-s1-20-6   pig carcass     Unknown         55              CHL                         Yes           *IntI1*

  *sul3*               v2-s1-1-9    pig carcass     Unknown         33              CHL                         Yes           *IntI1*
  ---------------------------------------------------------------------------------------------------------------------------------------

AMP: ampicillin; AUG: amoxillin + clavulanat; CHL: chloramphenicol GEN: gentamicin; SPE: spectinomycin; STR: streptomycin; NEO: neomyxin; SMX: sulfamethoxazole; TET: tetracycline; TMP: trimethoprim.

^a^conjugation not conducted.

Additional phenotypically expressed resistances were co-transferred with sulfonamide resistance by 55 plasmids (96%), resulting in diverse resistance patterns (Table [2](#T2){ref-type="table"}) indicating possible co-selection for all three tested sulfonamide resistance genes. Overall, the most frequently co-transferred resistances were to streptomycin (54%), ampicillin (51%) and trimethoprim (46%). These three resistances were co-transferred more frequently by *sul2*plasmids than those by *sul1*and *sul3*plasmids with highest frequency for streptomycin and ampicillin resistance (both 79%), indicating that the use of these antimicrobials possibly contribute to the predominance of the *sul2*gene via co-selection, which corroborates previous studies by Bean *et al.*\[[@B1],[@B2]\]. Tetracycline resistance was co-transferred in 16 plasmids carrying *sul1*and/or *sul2*genes. Chloramphenicol resistance was found to be co-transferred in 7 plasmids with 6 of them being *sul3*associated. The strong link between chloramphenicol resistance and *sul3*presence has already been reported for *Salmonella*and *E. coli*\[[@B9],[@B23]\].

The presence of *intI1*was detected in *sul1*(71%), *sul2*(17%) and *sul3*(100%) -carrying plasmids from all three sample reservoirs (Table [2](#T2){ref-type="table"}). Two out of 28 *intI1*-carrying plasmids could not be transferred by conjugation. Only one of 57 isolates carrying the *sul2*plasmid contained *intI2*. It is interesting to note, that all *sul3*plasmids were conjugative and harbored *intI1*as recently detected \[[@B9]\]. The association of *sul3*-carrying conjugative plasmids with integrons in *E. coli*isolates from pigs (carcass or feces) could probably facilitate the further spread of this gene to other bacteria and reservoirs via food chain.

Plasmid analysis and replicon typing
------------------------------------

S1 nuclease digestion followed by PFGE showed that the 15 plasmids carrying single *sul1*genes ranged from 33-160 kb in size. Replicon typing demonstrated seven different incompatibility groups (I1, N, FIB, FIA, HI1, FII and B/O) for the plasmids (Table [2](#T2){ref-type="table"}). IncI1 was the most common group, accounting for 5 *intI1*-containing conjugative plasmids (from pig feces and carcasses). Out of the six *sul1*plasmids originating from human specimens, four belonged to FI or FII type (three plasmids had multireplicons FIA-FIB or FII-FIB), one plasmid belonged to B/O and one plasmid could not be assigned. This replicon profile in human *E. coli*isolates seems different from those found in *E. coli*from pigs which mostly belonged to I1 and N. Due to the limited number of strains obtained from each source, a firm conclusion on whether specific replicon profiles are associated with pigs or humans would require the testing of additional strains.

The 25 *sul2*-carrying plasmids ranged from 33-120 kb in size. Five different incompatibility groups (FII, B/O, FIB, I1 and FIA) were demonstrated (Table [2](#T2){ref-type="table"}). Among them FII was the predominant replicon type (52%) and distributed equally in *E. coli*from the three sources. This is in contrast to a study in the UK where the FII replicon was not detected in 33 *sul2*-carrying plasmids in *E. coli*isolated from hospitals \[[@B1]\]. The 15 FII plasmids were similar in size (33-55 kb) and none contained *intI1*. However, the plasmids were associated with various resistance phenotypes and conjugation capabilities. It is possible that they represent the same plasmid backbone circulating in pigs and humans. The B/O replicon type was found in plasmids from *E. coli*isolated from both human and pig, but with different resistance profiles, indicating they are different plasmids sharing the same backbone. FIA, FIB, and I1 replicons were also found to be associated with *sul2*genes. Three *sul2*-carrying plasmids were negative for all the tested Inc groups. For the four plasmids carrying both *sul1*and *sul2*genes, two harbored the FIB replicon alone, one harbored FIB-FII and one had FIA-FIB-FII multireplicons.

Overall, IncF (FIA, FIB, FIC and FII) seemed to be the most common replicon associated with *sul2*, accounting for 72% *sul2*-carrying plasmids (21/29). IncF plasmids, which are considered having a narrow host range and being conjugative, seemed to be well adapted to *E. coli*as it was found in more than 50% of *E. coli*strains from different sources (especially FIB and FII) \[[@B24],[@B25]\]. Localization on common plasmids such as IncF could indicate transmission between the three reservoirs studied.

The 11 *sul3*-carrying plasmids ranged from 33-115 kb in size. Replicon typing detected five different incompatibility groups: I1, FII, FIB, FIC and X1 (Table [2](#T2){ref-type="table"}). IncI1 was found to be the most prevalent (45%) and all were conjugative and associated with class 1 integrons. The IncI1 plasmids had similar sizes, but differed in the resistance profiles. FII, X1 and FIB-FIC were also found to be associated with the *sul3*gene. Two *sul3*-carrying plasmids were negative for all the tested Inc groups.

When comparing plasmid size and the resistance phenotype, we found that *E. coli*isolates with larger sized plasmids did not always show resistance to a higher number of different antimicrobials. For instance, the 120 kb-sized plasmid contained in isolate 70-141-6 was only associated with resistance to tetracycline (Table [2](#T2){ref-type="table"}). However, isolates with smaller plasmids of only 33-kb size (isolates 3816 and 3837) showed resistance to ampicillin, streptomycin, tetracycline and trimethoprim. This indicates that resistance genes only account for a small part of the plasmid gene sequence and more studies are needed to determine the contents and function of such plasmids.

The findings of diverse incompatibility groups among various *sul*genes indicate that *sul*genes have been able to transfer into multiple plasmid backbones on multiple occasions, or that the plasmid backbones have diversified extensively since the acquisition of *sul*genes \[[@B1]\]. The IncF in our study was the most prevalent, carrying FII alone or in combination with FIA or/and FIB or/and FIC (multireplicon). This suggests that these plasmids are evolving through replicon sequence divergence, mosaicism and replicon co-integration in resolution process \[[@B26]\]. As human stays on the top of the food chain, the *sul*plasmids from healthy human reflects a more mixed population compared with pig or pork (partly represented by pig carcasses) also reflecting other reservoirs that connected to the farm to fork chain.

*Sul*-carrying plasmids in pig feces and on pig carcasses represent a pool of resistance genes that may transfer to human via the food chain, the most important non-human reservoir for transmission of antimicrobial resistance to humans. In fact, the colonization of sulfonamide-resistant *E. coli*from animal sources (chicken or pig) into the human gut has been successfully demonstrated in both *in vitro*and *in vivo*studies \[[@B27],[@B28]\]. The transfer of the *sul2*gene from an *E. coli*strain of a pig origin to a sulfonamide-sensitive *E. coli*strain of human origin was demonstrated in the intestine of mice and transfer of *sul2*has also been detected among *E. coli*in the human intestine \[[@B15]\]. By combining all these date it could be speculated that consumption of pork contaminated with sulfonamide-resistant *E. coli*could result in the transfer of *sul*genes from pigs to humans.

Conclusions
===========

To our knowledge, this is the first study to assess the plasmid replicons involved in various *sul*genes from different reservoirs. The diverse replicon profiles indicate no clear association between the replicon types and specific *sul*genes or sample sources. However, the localization of *sul*genes on wide spread replicons such as IncF is very likely to contribute to the dissemination of sulfonamide resistance. In addition, all *sul3*-carrying plasmids were found to be conjugative and associated with class 1 integrons. This underscores the potential of *sul3*to become more widespread in the future.
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